We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Genome Editing

News List

Lilly to collaborate with Precision BioSciences on genome editing research pharmatimes
November 24, 2020
Eli Lilly has entered a research collaboration and exclusive license agreement with Precision BioSciences to use genome editing to develop therapies for genetic disorders.
Intellia Therapeutics and Novartis Expand Cell Therapy Collaboration to Pursue CRISPR/Cas9-based Genome Editing in Additional Stem Cell Population americanpharmaceuticalreview
December 10, 2018
Intellia Therapeutics, Inc., a genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo.....
Thermo Fisher releases GeneArt products in China biospectrumasia
September 05, 2018
GeneArt products will help customers accelerate the path from planning experiments to executing them in the lab.
Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children americanpharmaceuticalreview
May 18, 2018
The two-year collaboration will employ Merck's CRISPR genome-editing technology in research studies by Dr. Jeffrey Gordon of Washington University School of Medicine.